Piyamitr Sritara

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Dharam J. Kumbhani, Philippe Gabríel Steg, Christopher P. Cannon et al. · European Heart Journal · 2014 · 318 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +11

A Risk Score for Predicting Incident Diabetes in the Thai Population

Wichai Aekplakorn, Pongamorn Bunnag, Mark Woodward et al. · Diabetes Care · 2006 · 278 citations · Full text

Computing, Chronic Disease Prevention, Health Sciences +17

Risk Factors for Development of Decreased Kidney Function in a Southeast Asian Population

Somnuek Domrongkitchaiporn, Piyamitr Sritara, Chagriya Kitiyakara et al. · Journal of the American Society of Nephrology · 2005 · 209 citations

Medicine, Nephrology, Hemodialysis +14

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17